Platinum-sensitive ovarian carcinoma

Clinical trials for Platinum-sensitive ovarian carcinoma explained in plain language.

Never miss a new study

Get alerted when new Platinum-sensitive ovarian carcinoma trials appear

Sign up with your email to follow new studies for Platinum-sensitive ovarian carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 4

New cocktail aims to boost immune attack on ovarian cancer

Disease control Recruiting now

This phase 2 trial tests whether adding an experimental immune-boosting drug (CDX-1140) to two standard immunotherapies (pembrolizumab and bevacizumab) can shrink tumors in people whose ovarian cancer has returned. About 80 adults with recurrent ovarian, fallopian tube, or perito…

Matched conditions: PLATINUM-SENSITIVE OVARIAN CARCINOMA

Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

Platinum-sensitive ovarian carcinoma

Get alerted when new Platinum-sensitive ovarian carcinoma trials appear

New cocktail aims to boost immune attack on ovarian cancer